UPDATE : Friday, June 5, 2020
상단여백
PREV NEXT
  • 1
  • 2
  • 3
  • Pharma
    Rinvoq joins competition among JAK inhibitors
    HeadLine News
  • 여백
    여백
    [ASCO 2020 ⑤] Lunit opens possibility of personalized cancer treatment with AI platform
    [ASCO 2020 ④] MedPacto's Vactosertib combo treatment for desmoid tumors proved safe
    [ASCO 2020 ③] Genexine’s combo therapy for breast cancer proves safety
    [ASCO 2020 ②] GC confirms safety, efficacy of anti-EGFR monoclonal antibody
    여백
    여백
    여백
    여백
    여백
    여백
    여백
    여백
    여백
    Back to Top